INTEGRATED BIOPHARMA INC APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
INTEGRATED BIOPHARMA INC (INBP) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $50.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-05-08
- INTEGRATED BIOPHARMA INC apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $50.00K, a 11.11% increase year-over-year.
- INTEGRATED BIOPHARMA INC apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-12-31 was $42.00K, a 2.33% decline year-over-year.
- INTEGRATED BIOPHARMA INC apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-09-30 was $49.00K, a 7.55% decline year-over-year.
- INTEGRATED BIOPHARMA INC apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-03-31 was $45.00K, a 25.00% decline year-over-year.
- INTEGRATED BIOPHARMA INC apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $185.00K, a 26.59% decline from fiscal 2024.
- INTEGRATED BIOPHARMA INC apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $252.00K, a 21.25% decline from fiscal 2023.
- INTEGRATED BIOPHARMA INC apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $320.00K, a 13.28% decline from fiscal 2022.
- INTEGRATED BIOPHARMA INC apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $369.00K, a 59.74% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-03-31 | $50.00K 10-Q · filed 2026-05-08 | $92.00K derived: sum of 2 quarters · filed 2026-05-08 | $141.00K derived: sum of 3 quarters · filed 2026-05-08 | |
| 2025-12-31 | $42.00K 10-Q · filed 2026-05-08 | $91.00K derived: sum of 2 quarters · filed 2026-05-08 | ||
| 2025-09-30 | $49.00K 10-Q · filed 2026-05-08 | |||
| 2025-06-30 | $185.00K 10-K · filed 2025-09-23 | |||
| 2025-03-31 | $45.00K 10-Q · filed 2026-05-08 | $88.00K derived: sum of 2 quarters · filed 2026-05-08 | $141.00K derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $43.00K 10-Q · filed 2026-05-08 | $96.00K derived: sum of 2 quarters · filed 2026-05-08 | ||
| 2024-09-30 | $53.00K 10-Q · filed 2026-05-08 | |||
| 2024-06-30 | $252.00K 10-K · filed 2025-09-23 | |||
| 2024-03-31 | $60.00K 10-Q · filed 2025-05-14 | $122.00K derived: sum of 2 quarters · filed 2025-05-14 | $193.00K derived: sum of 3 quarters · filed 2025-05-14 | |
| 2023-12-31 | $62.00K 10-Q · filed 2025-05-14 | $133.00K derived: sum of 2 quarters · filed 2025-05-14 | ||
| 2023-09-30 | $71.00K 10-Q · filed 2025-05-14 | |||
| 2023-06-30 | $320.00K 10-K · filed 2024-09-20 | |||
| 2023-03-31 | $73.00K 10-Q · filed 2024-05-10 | $159.00K derived: sum of 2 quarters · filed 2024-05-10 | $240.00K derived: sum of 3 quarters · filed 2024-05-10 | |
| 2022-12-31 | $86.00K 10-Q · filed 2024-05-10 | $167.00K derived: sum of 2 quarters · filed 2024-05-10 | ||
| 2022-09-30 | $81.00K 10-Q · filed 2024-05-10 | |||
| 2022-06-30 | $369.00K 10-K · filed 2023-09-15 | |||
| 2022-03-31 | $108.00K 10-Q · filed 2023-05-11 | $253.00K derived: sum of 2 quarters · filed 2023-05-11 | $290.00K derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $145.00K 10-Q · filed 2023-05-11 | $182.00K derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-09-30 | $37.00K 10-Q · filed 2023-05-11 | |||
| 2021-06-30 | $231.00K 10-K · filed 2022-09-13 | |||
| 2021-03-31 | $68.00K 10-Q · filed 2022-05-12 | $154.00K derived: sum of 2 quarters · filed 2022-05-12 | $162.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $86.00K 10-Q · filed 2022-05-12 | $94.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-09-30 | $8.00K 10-Q · filed 2022-05-12 | |||
| 2020-06-30 | $59.00K 10-K · filed 2021-09-02 | |||
| 2020-03-31 | $14.00K 10-Q · filed 2021-05-13 | $29.00K derived: sum of 2 quarters · filed 2021-05-13 | $44.00K derived: sum of 3 quarters · filed 2021-05-13 | |
| 2019-12-31 | $15.00K 10-Q · filed 2021-05-13 | $30.00K derived: sum of 2 quarters · filed 2021-05-13 | ||
| 2019-09-30 | $15.00K 10-Q · filed 2021-05-13 | |||
| 2019-06-30 | $144.00K 10-K · filed 2020-09-23 | |||
| 2018-06-30 | $14.00K 10-K · filed 2019-08-29 | |||
| 2017-06-30 | $49.00K 10-K · filed 2018-09-12 | |||
| 2016-06-30 | $31.00K 10-K · filed 2017-09-01 | |||
| 2015-06-30 | $104.00K 10-K · filed 2016-09-02 |